The role of surgery in the management of malignant pleural mesothelioma

Journal of B.U.ON.

Volumn 14, Issue 2, 2009, Pages 173-181

  Foroulis, Christophoros N ^a   Zarogoulidis, K ^a   Papakonstantinou, C ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cytoreductive surgery; Extrapleural pneumonectomy; Malignant pleural mesothelioma; Pleural tumors; Pleurectomy decortication; Video assisted thoracoscopy

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL RESEARCH; CLINICAL TRIAL; DECORTICATION; DYSPNEA; HUMAN; LUNG RESECTION; METASTASIS; MORBIDITY; MORTALITY; PHOTODYNAMIC THERAPY; PLEURA CAVITY; PLEURA MESOTHELIOMA; PLEURECTOMY; QUALITY OF LIFE; REVIEW; THORACOSCOPY; TREATMENT PLANNING;

HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS; PNEUMONECTOMY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67651046766     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Robinson WBS, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005; 336: 397-408.
2. Bueno R, Gordon GJ. Genetics of malignant pleural mesothelioma: molecular markers and biologic targets. Thorac Surg Clin 2004; 14: 461-468. (Pubitemid 39314479)
3. Zellos L, Christiani DC. Epidemiology, biologic behavior and natural history of mesothelioma. Thorac Surg Clin 2004; 14; 469-477. (Pubitemid 39314480)
4. Cersoli GL, Gridelli C, Santoro R. Multidisciplinary treatment of malignant pleural mesothelioma. The Oncologist 2007; 12: 850-863. (Pubitemid 47328228)
5. Paul S, Neragi-Miandoab S, Jaklitsch MT. Preoperative assessment and therapeutic options for patients with malignant pleural mesothelioma. Thorac Surg Clin 2004; 14: 505-516. (Pubitemid 39314484)
6. Truong MT, Marom EM, Erasmus JJ. Preoperative evaluation of patients with malignant pleural mesothelioma: Role of integrated CT-PET imaging. J Thoracic Imaging 2006; 21: 146-153.
7. BTS statement on malignant mesothelioma in the UK, 2007. British Thoracic Society Standards of Care Committee. Thorax 2007: 62 (Suppl 2): ii1-ii19.
8. Stojsic J, Spasic Z, Velinovic M et al. Diagnostic procedures for malignant pleural mesothelioma: our experience. J BUON 2004; 9: 423-426. (Pubitemid 40277975)
9. Scherpereel A, French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma. Resp Med 2007; 101: 1265-1276. (Pubitemid 46671140)
10. Foroulis C, Kotoulas C, Konstantinou M, Lioulias A. The management of malignant pleural effusions: talc pleurodesis versus bleomycin pleurodesis. J BUON 2001; 6: 397-400. (Pubitemid 34071271)
11. Shaw P, Agrawal R. Pleurodesis for malignant pleural effusions. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD002916. DOI: 10.1002/14651858.CD002916.pub2
12. Brubacher S, Gobel BH. Use of the Pleurx Pleural Catheter for the management of malignant pleural effusions. Clin J Oncol Nurs 2003; 7: 35-38.
13. Muirhead R, O'Rourke N. Drain site radiotherapy in malignant pleural mesothelioma: a wasted resource. Eur Resp J 2007; 30: 1021. (Pubitemid 351194808)
14. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with malignant pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995; 108: 754-758.
15. Low EM, Khoury GG, Matthews EW, Neville E. Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy. Clin Oncol (R Coll Radiol) 1995; 7: 317-318.
16. Bydder S, Phillips M, Joseph DJ et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer 2004; 91: 9-10. (Pubitemid 39013037)
17. Cellerin L, Garry P, Mahe MA, Chailleux E. Malignant pleural mesothelioma: radiotherapy for the prevention of seeding nodules. Rev Mal Respir 2004; 21: 53-58. (Pubitemid 38477842)
18. Pinto C, Sperandi F, Marino A, Mutri V, Martoni A. Is prophylactic radiotherapy necessary as prevention of tumor seeding following thoracoscopy in malignant pleural mesothelioma (MPM)? Lung Cancer 2005; 49 (Suppl 2): S227 (abstr).
19. West SD, Foord T, Davies RJ. Needle-track metastases and prophylactic radiotherapy for malignant mesothelioma. Respir Med 2006; 100: 1037-1040.
20. O'Rourke N, Garcia JC, Paul J, Lawless C, McMenemin R, Hill J. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol 2007; 84: 18-22. (Pubitemid 47030694)
21. Flores RM. The role of PET in the surgical management of malignant pleural mesothelioma. Lung Cancer 2005; 49 (Suppl 1): S27-S32. (Pubitemid 40798841)
22. van Meerbeeck JP, Boyer M. Consensus report: pre-treatment minimal staging and treatment of potentially resectable malignant pleural mesothelioma. Lung Cancer 2005; 49 (Suppl 1): S123-S127. (Pubitemid 40798862)
23. Rice DC, Erasmus JJ, Stevens CW et al. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 2005; 80: 1988-1993.
24. Alvarez JM, Musk W, Robins P, Price R, Byrne MJ. Importance of mediastinoscopy, bilateral thoracoscopy, and laparoscopy in correct staging of malignant mesothelioma before extrapleural pneumonectomy. J Thorac Cardiovasc Surg 2005; 130: 905-906. (Pubitemid 41265749)
25. Sugarbaker DJ, Flores RM, Jaklitsch MT et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999; 117: 54-65.
26. de Perrot M, Uy K, Anraku M et al. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2007; 133: 111-116. (Pubitemid 46014196)
27. Sterman DH, Kaiser LR, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest 1999; 16: 504-520. (Pubitemid 29382138)
28. Cowan SW, Pechet TT. Pleurectomy and decortication for malignant mesothelioma. Thorac Surg Clin 2004; 14: 517-521.
29. Philips PG, Asimakopoulos G, Mainwand O. Malignant pleural mesothelioma: outcome of limited surgical management. Inter Cardiovasc Thorac Surg 2003; 2: 30-34. (Pubitemid 37443554)
30. Cameron RB. Extrapleural pneumonectomy is the preferred surgical management in the multimodality therapy of pleural mesothelioma: Con argument. Ann Surg Oncol 2007; 14: 1249-1253.
31. Moghissi K. Pleural neoplasms. In: Moghissi K, Thorpe JAC, Giulli F (Eds): Moghissi's Essentials of Thoracic and Cardiovascular surgery. Elsevier Science B.V., Amsterdam - Netherlands, 2003, pp 205-210.
32. Martin-Ukar AE, Nakas A, Edwards JG, Waller DA. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 2007; 31: 765-771. (Pubitemid 46528743)
33. Neragi-Miandoab S. Multimodality approach in management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2006; 29: 14-19. (Pubitemid 43000349)
34. Rusch V, Saltz L, Venkatraman E et al. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 1994; 12: 1156-1163. (Pubitemid 24173928)
35. Lee JD, Perez S, Wang HJ, Figlin RA, Holmes EC. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience. J Surg Oncol 1995; 60: 262-267. (Pubitemid 26004391)
36. Sauter ER, Langer C, Coia LR, Goldberg M, Keller SM. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. J Surg Oncol 1995; 60: 100-105.
37. Colleoni M, Sartori F, Calabro F et al. Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma. Tumori 1996; 82: 53-56. (Pubitemid 26147211)
38. Alberts AS, Falkson F, Goehdals L, Vorobiof DA, Van Der Merwe CA. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol 1988; 6: 527-535.
39. Achatzy R, Beba W, Ritschhler R et al. The diagnosis, therapy and prognosis of diffuse malignant mesothelioma. Eur J Cardiothorac Surg 1989; 3: 445-447.
40. Ball DL, Cruickshank DG. The treatment of malignant mesothelioma of the pleura: review of five year experience, with special reference to radiotherapy. Am J Clin Oncol 1990; 13: 4-9.
41. Brancatisano RP, Joseph MG, McCaughan BC. Pleurectomy for mesothelioma. Med J Austria 1991; 154: 455-458.
42. Soysal O, Karaoglanoglu N, Demiracan S et al. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 1997; 11: 210-213. (Pubitemid 27096656)
43. Ceresoli GL, Locati LD, Ferreri AJ et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 2001; 34: 279-287.
44. Lee TT, Everett DL, Shu HK et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2002; 124: 1183-1189.
45. Maziak DE, Gagliardi A, Haynes AE, Mackay JA, Evans WK. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer 2005; 48: 157-169. (Pubitemid 40501805)
46. Sugarbaker DJ. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol 2007; 1: 175-176.
47. Chang MY, Sugarbaker DJ. Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications. Thorac Surg Clin 2004; 14: 523-530. (Pubitemid 39314486)
48. Miller DI. Extrapleural pneumonectomy. www.ctsnet.org/sections/ clinicalresources/thoracic/expert-tech-7.html
49. Sugarbaker DJ, Jaklitsch MT, Bueno R et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004; 128: 138-146. (Pubitemid 38881208)
50. de Perrot M, McRae K, Anraku M et al. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg 2008; 85: 1206-1210.
51. Janne PA, Baldini EH. Patterns of failure following surgical resection for malignant pleural mesothelioma. Thorac Surg Clin 2004; 14: 567-573.
52. Treasure T, Tan C, Lang-Lazdunski L, Waller D. The MARS trial: mesothelioma and radical surgery. Interact Cardiovasc Thorac Surg2006; 5: 58-59.
53. Weder W, Stahel RA, Bernhard J et al. On behalf of the Swiss group for clinical cancer research. Multicenter trial on neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007; 18: 1196-1202.
54. Lucchi M, Chella A, Melfi F et al. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma. Eur J Cardiothorac Surg 2007; 31: 529-535. (Pubitemid 46329391)
55. Rea F, Marulli G, Bortolotti L et al. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results. Lung Cancer 2007; 57: 89-95. (Pubitemid 46843340)
56. Flores RM, Krug LM, Rosenweig KE et al. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma. J Thorac Oncol 2006; 1: 289-295.
57. Opitz I, Kestenholz P, Lardinois D et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2006; 29: 579-584.
58. Treasure T, Sedranyan A. Pleural mesothelioma: little evidence, still time to do trials. Lancet 2004; 364: 1183-1185.
59. Aelony Y, Yao JE. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series. Respirology 2005; 10: 649-655. (Pubitemid 44944463)
60. Moghissi K, Dixon K. Photodynamic therapy in the management of malignant pleural mesothelioma: A review. Photodiag Photodyn Ther 2005; 2: 135-147. (Pubitemid 41160483)
61. Ris HB. Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma. Lung Cancer 2005; 49 (Suppl 1): S65-S68. (Pubitemid 40798849)